Bacteriostatic Water for Injection - Dosage and Administration
Zahraee H, Arab SS, Khoshbin Z et al (2024) Molecular dynamics simulation as a promising approach for computational study of liquid crystal-based aptasensors
Poster Session II - ACUTE ISCHEMIC STROKE MANAGEMENT 01.00 - ACUTE ISCHEMIC STROKE MANAGEMENT - 01.01 - ACUTE MANAGEMENT - Neither thrombolysis nor thrombectomy P654 - ESOC25-1345 THE METOCLOPRAMIDE FOR AVOIDING PNEUMONIA AFTER STROKE (MAPS-2): A SINGLE-BLIND RANDOMIZED CONTROLLED TRIAL OF METOCLOPRAMIDE FOR PREVENTION OF PNEUMONIA AFTER STROKE Anushka Warusevitane 1 , Craig Smith 2 , Anand Dixit 3 , Nikola Sprigg 4 , Reuben Ogollah 5 , Julius Sim 6 , Sue Jowett 7 , Diane Havard 4 , Lesia Kurlak 4 , Rebecca Ward 4 , Jared Palmer 4 , Iris Isheanesu Mhlanga 4 , Corinne Latulipe 4 , Lee Haywood 4 , Lisa Woodhouse 4 , Philip Bath 4 , Christine Roffe 1,6 1 Royal Stoke University Hospital, Stoke on Trent, United Kingdom, 2 Division of Cardiovascular Sciences, University of Manchester, Manchester, United Kingdom, 3 Freeman Hospital, Newcastle upon Tyne, United Kingdom, 4 Stroke Trials Unit, Mental Health and Clinical Neurosciences, University of Nottingham, Nottingham, United Kingdom, 5 Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, United Kingdom, 6 School of Medicine, Keele University, Keele, United Kingdom, 7 Health Economics Unit, University of Birmingham, Birmingham, United Kingdom Background and Aims: Pneumonia causes more deaths than neurological damage after stroke
Gastrointestinal protection: Consistent with its origins in gastric juice protein, BPC-157 has demonstrated protective and healing effects on gastrointestinal mucosa, including in models of inflammatory bowel disease, ulcers, and esophageal damage (5)
